Cargando…

A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles

INTRODUCTION: The relevance of the cerebrospinal fluid (CSF) biomarkers for the diagnosis of Alzheimer’s disease (AD) and related disorders is clearly established. However, the question remains on how to use these data, which are often heterogeneous (not all biomarkers being pathologic). The objecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lehmann, Sylvain, Dumurgier, Julien, Schraen, Susanna, Wallon, David, Blanc, Frédéric, Magnin, Eloi, Bombois, Stéphanie, Bousiges, Olivier, Campion, Dominique, Cretin, Benjamin, Delaby, Constance, Hannequin, Didier, Jung, Barbara, Hugon, Jacques, Laplanche, Jean-Louis, Miguet-Alfonsi, Carole, Peoc’h, Katell, Philippi, Nathalie, Quillard-Muraine, Muriel, Sablonnière, Bernard, Touchon, Jacques, Vercruysse, Olivier, Paquet, Claire, Pasquier, Florence, Gabelle, Audrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255520/ https://www.ncbi.nlm.nih.gov/pubmed/25478015 http://dx.doi.org/10.1186/alzrt267

Ejemplares similares

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study
por: Dumurgier, Julien, et al.
Publicado: (2015)

What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France
por: Cognat, Emmanuel, et al.
Publicado: (2019)

Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study
por: Paquet, Claire, et al.
Publicado: (2016)

New highly sensitive rodent and human tests for soluble amyloid precursor protein alpha quantification: preclinical and clinical applications in Alzheimer’s disease
por: Rose, Christiane, et al.
Publicado: (2012)

Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function
por: Lehmann, Sylvain, et al.
Publicado: (2023)

Neglected Comorbidity of Chronic Heart Failure: Iron Deficiency
por: Manceau, Hana, et al.
Publicado: (2022)

Iron deficiency markers in patients undergoing iron replacement therapy: a 9-year retrospective real-world evidence study using healthcare databases
por: Cacoub, Patrice, et al.
Publicado: (2020)

Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms
por: Uzzan, Mathieu, et al.
Publicado: (2020)

Memory Outcome in Prodromal and Mild Dementia with Lewy Bodies and Alzheimer’s Disease: A Longitudinal Study
por: Querry, Manon, et al.
Publicado: (2023)

CSF in Epileptic Prodromal Alzheimer's Disease: No Diagnostic Contribution but a Pathophysiological One
por: Cretin, Benjamin, et al.
Publicado: (2021)

Genotyping Test with Clinical Factors: Better Management of Acute Postoperative Pain?
por: Hajj, Aline, et al.
Publicado: (2015)

Ferroptosis in Liver Diseases: An Overview
por: Capelletti, Martina Maria, et al.
Publicado: (2020)

Iron Metabolism in Normal and Pathological Pregnancies and Fetal Consequences
por: Mégier, Charles, et al.
Publicado: (2022)

Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ(1–42) and Tau Proteins in Elderly Patients With Mild Cognitive Impairment
por: Duron, Emmanuelle, et al.
Publicado: (2018)

Corrigendum: Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aß(1−42), and Tau Proteins in Elderly Patients With Mild Cognitive Impairment
por: Duron, Emmanuelle, et al.
Publicado: (2019)

Smoking Induces Long-Lasting Effects through a Monoamine-Oxidase Epigenetic Regulation
por: Launay, Jean-Marie, et al.
Publicado: (2009)

Cerebrospinal Fluid PKR Level Predicts Cognitive Decline in Alzheimer’s Disease
por: Dumurgier, Julien, et al.
Publicado: (2013)

Smoking Related Diseases: The Central Role of Monoamine Oxidase
por: Rendu, Francine, et al.
Publicado: (2011)

Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals
por: Lehmann, Sylvain, et al.
Publicado: (2020)

Reversible atransferrinemia in a patient with chronic enteropathy: is transferrin mandatory for iron transport?
por: Raynor, Alexandre, et al.
Publicado: (2022)

APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases
por: Lanoiselée, Hélène-Marie, et al.
Publicado: (2017)

Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLM(R) Scale
por: Lehmann, Sylvain, et al.
Publicado: (2018)

Pro-Apoptotic Kinase Levels in Cerebrospinal Fluid as Potential Future Biomarkers in Alzheimer’s Disease
por: Paquet, Claire, et al.
Publicado: (2015)

Sample Pooling and Inflammation Linked to the False Selection of Biomarkers for Neurodegenerative Diseases in Top–Down Proteomics: A Pilot Study
por: Molinari, Nicolas, et al.
Publicado: (2018)

Prodromal characteristics of dementia with Lewy bodies: baseline results of the MEMENTO memory clinics nationwide cohort
por: Blanc, Frederic, et al.
Publicado: (2022)

I-FABP is decreased in COVID-19 patients, independently of the prognosis
por: Guedj, Kevin, et al.
Publicado: (2021)

Central Nervous System and Peripheral Inflammatory Processes in Alzheimer’s Disease: Biomarker Profiling Approach
por: Delaby, Constance, et al.
Publicado: (2015)

Neurofilaments contribution in clinic: state of the art
por: Delaby, Constance, et al.
Publicado: (2022)

Regulating Factors of PrP(res) Glycosylation in Creutzfeldt-Jakob Disease - Implications for the Dissemination and the Diagnosis of Human Prion Strains
por: Levavasseur, Etienne, et al.
Publicado: (2008)

Correction: Regulating Factors of PrP(res) Glycosylation in Creutzfeldt-Jakob Disease - Implications for the Dissemination and the Diagnosis of Human Prion Strains
por: Levavasseur, Etienne, et al.
Publicado: (2008)

Phenotype and imaging features associated with APP duplications
por: Grangeon, Lou, et al.
Publicado: (2023)

PKR involvement in Alzheimer’s disease
por: Hugon, Jacques, et al.
Publicado: (2017)

617. Efficacy of Dimercaptosuccinic Acid (DMSA), a Zinc Chelator, in Combination with Imipenem Against Metallo-β-Lactamase Producing Escherichia coli in a Murine Peritonitis Model
por: Cheminet, Geoffrey, et al.
Publicado: (2019)

Kinetics of serum hepcidin and interleukin-6 levels following COVID-19 infection in hemodialysis patients
por: Touzot, Maxime, et al.
Publicado: (2021)

Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview
por: Delaby, Constance, et al.
Publicado: (2021)

Palmomental Reflex a Relevant Sign in Early Alzheimer’s Disease Diagnosis?
por: Gabelle, Audrey, et al.
Publicado: (2015)

How many patients are eligible for disease-modifying treatment in Alzheimer’s disease? A French national observational study over 5 years
por: Epelbaum, Stéphane, et al.
Publicado: (2019)

Accuracy of citrulline, I-FABP and d-lactate in the diagnosis of acute mesenteric ischemia
por: Nuzzo, Alexandre, et al.
Publicado: (2021)

Improving clinical suspicion of acute mesenteric ischemia among patients with acute abdomen: a cross-sectional study from an intestinal stroke center
por: Nuzzo, Alexandre, et al.
Publicado: (2023)

Early care of N-acetyl glutamate synthase (NAGS) deficiency in three infants from an inbred family
por: Peoc'h, Katell, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2q5vg111jvo3j8cbh39a4a06av